Infliximab


( Last Updated : June 17, 2014)
Generic Name:
Infliximab
Project Status:
Complete
Therapeutic Area:
Ankylosing spondylitis; arthritis, psoriatic; arthritis, rheumatoid; plaque psoriasis
Manufacturer:
Hospira Healthcare Corporation
Call for patient/clinician input open:
Brand Name:
Inflectra
Project Line:
Reimbursement Review
Project Number:
SE0384-000
Call for patient/clinician input closed:

Details


Biosimilar:
Yes
Submission Type:
Initial
Indications:
Ankylosing spondylitis, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis
Recommendation Type:
List with criteria/condition
Final Recommendation: